Cardiovascular Solutions, LLC

Shreveport, Louisiana 71103

1 studies enrolling now · 3 studies all time

What they study most

Lower Extremity Arterial Disease, Percutaneous Coronary Intervention, Peripheral Arterial Disease, Peripheral Endovascular Intervention, Primary Prevention of Atherosclerotic Cardiovascular Disease

Studies at this site

• Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention — Recruiting now
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• EverFlex Post Approval Study — Completed